AXIM Biotechnologies, Inc. (AXIM) stock
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)
Close on Oct 19, 2026Market cap –P/E –Yield –
AXIM Biotechnologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
AXIM Biotechnologies's free cash flow for the twelve months ending Dec 31, 2023 was -$1.03M. For fiscal 2023 it was -$1.03M. The highest annual figure on record is -$339.00K in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$1.03M | – |
| FY2022 | Dec 31, 2022 | -$2.05M | – |
| FY2021 | Dec 31, 2021 | -$2.53M | – |
| FY2020 | Dec 31, 2020 | -$3.31M | – |
| FY2016 | Dec 31, 2016 | -$1.29M | – |
| FY2015 | Dec 31, 2015 | -$1.52M | – |
| FY2014 | Dec 31, 2014 | -$339.00K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -$255.35K | – |
| Q4 FY2023 | Dec 31, 2023 | $19.56K | – |
| Q4 FY2022 | Dec 31, 2022 | -$315.51K | – |
| Q3 FY2022 | Sep 30, 2022 | -$323.94K | – |
| Q4 FY2021 | Dec 31, 2021 | -$813.41K | – |
| Q4 FY2016 | Dec 31, 2016 | -$532.45K | – |
| Q4 FY2015 | Dec 31, 2015 | -$385.22K | – |
| Q4 FY2014 | Dec 31, 2014 | -$288.68K | – |
See a number that looks wrong?